Validation of Isolated Metabolites from Drug Metabolism Studies as Analytical Standards by Quantitative NMR

被引:52
作者
Walker, Gregory S. [1 ]
Ryder, Tim F. [1 ]
Sharma, Raman [1 ]
Smith, Evan B. [2 ]
Freund, Amy [3 ]
机构
[1] Pfizer Global Res & Dev, Pharmacokinet Dynam & Metab Dept, Groton, CT USA
[2] Pfizer Global Res & Dev, Pharmacokinet Dynam & Metab Dept, La Jolla, CA USA
[3] Bruker BioSpin Corp, Billerica, MA USA
关键词
NATURAL-PRODUCTS; ERETIC METHOD; H-1-NMR; IDENTIFICATION; SPECTROSCOPY; STRATEGIES; QUALITY; SAFETY;
D O I
10.1124/dmd.110.036343
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In discovery and development, having a qualified metabolite standard is advantageous. Chemical synthesis of metabolite standards is often difficult and expensive. As an alternative, biological generation and isolation of metabolites in the nanomole range are readily feasible. However, without an accurately defined concentration, these isolates have limited utility as standards. There is a significant history of NMR as both a qualitative and a quantitative technique, and these concepts have been merged recently to provide both structural and quantitative information on biologically generated isolates from drug metabolism studies. Previous methodologies relied on either specialized equipment or the use of an internal standard to the isolate. We have developed a technique in which a mathematically generated signal can be inserted into a spectrum postacquisition and used as a quantitative reference: artificial signal insertion for calculation of concentration observed (aSICCO). This technique has several advantages over previous methodologies. Any region in the analyte spectra, free from interference, can be chosen for the reference signal. In addition, the magnitude of the inserted signal can be modified to appropriately match the intensity of the sample resonances. Because this is postacquisition quantification, no special equipment or pulse sequence is needed. Compared with quantitation via the addition of an internal standard (10 mM maleic acid), the signal insertion method produced similar results. For each method, precision and accuracy were within +/- 5%, stability of signal response over 8 days was +/- 5%, and the dynamic range was more than 3 orders of magnitude: 10 to 0.01 mM.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 24 条
[1]   Concentration measurement by proton NMR using the ERETIC method [J].
Akoka, S ;
Barantin, L ;
Trierweiler, M .
ANALYTICAL CHEMISTRY, 1999, 71 (13) :2554-2557
[2]  
[Anonymous], 2008, GUID IND SAF TEST DR
[3]   NMR Quantitation of Natural Products at the Nanomole Scale [J].
Dalisay, Doralyn S. ;
Molinski, Tadeusz F. .
JOURNAL OF NATURAL PRODUCTS, 2009, 72 (04) :739-744
[4]   Evaluation of preparative high performance liquid chromatography and cryoprobe-nuclear magnetic resonance spectroscopy for the early quantitative estimation of drug metabolites in human plasma [J].
Dear, G. J. ;
Roberts, A. D. ;
Beaumont, C. ;
North, S. E. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 876 (02) :182-190
[5]   Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS [J].
Duarte, Iola F. ;
Legido-Quigley, Cristina ;
Parker, David A. ;
Swann, Jonathan R. ;
Spraul, Manfred ;
Braumann, Ulrich ;
Gil, Ana M. ;
Holmes, Elaine ;
Nicholson, Jeremy K. ;
Murphy, Gerard M. ;
Vilca-Melendez, Hector ;
Heatond, Nigel ;
Lindon, John C. .
MOLECULAR BIOSYSTEMS, 2009, 5 (02) :180-190
[6]   Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing [J].
Espina, Robert ;
Yu, Linning ;
Wang, Jianyao ;
Tong, Zeen ;
Vashishtha, Sarvesh ;
Talaat, Rasmy ;
Scatina, JoAnn ;
Mutlib, Abdul .
CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (02) :299-310
[7]   Drug safety, drug quality, drug analysis [J].
Goeroeg, Sandor .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (02) :247-253
[8]  
KALGUTKAR AS, 2008, BIOTECHNOL PHARM ASP, V9, P27
[9]   OXIDATIVE-METABOLISM OF CARBAZERAN INVITRO BY LIVER CYTOSOL OF BABOON AND MAN [J].
KAYE, B ;
RANCE, DJ ;
WARING, L .
XENOBIOTICA, 1985, 15 (03) :237-242
[10]   Chromatographic analysis of compounds of pharmaceutical interest [J].
Kuo, MS ;
Shilliday, FB ;
Yurek, DA .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2001, 39 (12) :513-520